VIICTR
Profiles
ORIT
Pediatrics RRO
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.
CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma. Clin Cancer Res. 2017 Dec 01; 23(23):7360-7374.
View in:
PubMed
subject areas
Adult
Aged
Animals
Antineoplastic Agents
Brain Neoplasms
Cell Line, Tumor
Cell Movement
Dasatinib
Disease-Free Survival
Female
Glioblastoma
Humans
Male
Mice
Middle Aged
Neoplastic Stem Cells
Prognosis
src-Family Kinases
Thy-1 Antigens
Xenograft Model Antitumor Assays
authors with profiles
RIVKAH COLEN